Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Advertise in Pharma in Focus

Advertising in Pharma in Focus delivers you:

  • Unique access to a $17 billion industry
  • High visibility with over 11,500 readers every working day
  • Great reaction with high click through rates
  • Unparalled contact via unique beyond-the-click services

For more information, ring 02 9938 4381

Approvals Action
Cancer therapies added
ALL and breast cancer drugs approved.
Pipeline Monitor
Lilly aims I-O at lung cancer
Mid-year global filing plans for Cyramza to treat NSCLC.
Top of the Hill
Danger in 'affordability' play
Labor's focus on meds cost threatens sector unity.